Abstract：
:Somatic genetic alterations of IKZF1, which encodes the lymphoid transcription factor IKAROS, are common in high-risk B-progenitor acute lymphoblastic leukemia (ALL) and are associated with poor prognosis. Such alterations result in the acquisition of stem cell-like features, overexpression of adhesion molecules causing aberrant cell-cell and cell-stroma interaction, and decreased sensitivity to tyrosine kinase inhibitors. Here we report coding germline IKZF1 variation in familial childhood ALL and 0.9% of presumed sporadic B-ALL, identifying 28 unique variants in 45 children. The majority of variants adversely affected IKZF1 function and drug responsiveness of leukemic cells. These results identify IKZF1 as a leukemia predisposition gene, and emphasize the importance of germline genetic variation in the development of both familial and sporadic ALL.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Churchman ML,Qian M,Te Kronnie G,Zhang R,Yang W,Zhang H,Lana T,Tedrick P,Baskin R,Verbist K,Peters JL,Devidas M,Larsen E,Moore IM,Gu Z,Qu C,Yoshihara H,Porter SN,Pruett-Miller SM,Wu G,Raetz E,Martin PL,Bowmandoi
10.1016/j.ccell.2018.03.021subject
Has Abstractpub_date
2018-05-14 00:00:00pages
937-948.e8issue
5eissn
1535-6108issn
1878-3686pii
S1535-6108(18)30126-0journal_volume
33pub_type
杂志文章相关文献
CANCER CELL文献大全abstract：:Ras and pRb are key regulators of a plethora of cellular processes, including proliferation, differentiation, and tumorigenesis. Adding to several previously established lines of communication between the two, in this issue of Cancer Cell, Shamma et al. resolve a new signaling network involved in cellular senescence a...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2009.03.007
更新日期：2009-04-07 00:00:00
abstract：:EGFRvIII, a frequently occurring mutation in primary glioblastoma, results in a protein product that cannot bind ligand, but signals constitutively. Deducing how EGFRvIII causes transformation has been difficult because of autocrine and paracrine loops triggered by EGFRvIII alone or in heterodimers with wild-type EGFR...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.09.004
更新日期：2013-10-14 00:00:00
abstract：:The EZH2 histone methyltransferase is highly expressed in germinal center (GC) B cells and targeted by somatic mutations in B cell lymphomas. Here, we find that EZH2 deletion or pharmacologic inhibition suppresses GC formation and functions. EZH2 represses proliferation checkpoint genes and helps establish bivalent ch...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.04.011
更新日期：2013-05-13 00:00:00
abstract：:Angiogenesis is a hallmark of solid tumors, and disruption of tumor vasculature is an active anticancer therapy in some cases. Several proteins expressed on the surface of tumor endothelium have been identified during the last decade. However, due to the expression in both physiological and tumor angiogenesis, only a ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2007.05.004
更新日期：2007-06-01 00:00:00
abstract：:The Twist1 transcription factor is known to promote tumor metastasis and induce Epithelial-Mesenchymal Transition (EMT). Here, we report that Twist1 is capable of promoting the formation of invadopodia, specialized membrane protrusions for extracellular matrix degradation. Twist1 induces PDGFRα expression, which in tu...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.01.036
更新日期：2011-03-08 00:00:00
abstract：:Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA damage response (DDR). In contrast, Myc activation-although producing a DDR as well-is known to primarily elicit an apoptotic countermeasure. Using the Emu-my...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2009.12.043
更新日期：2010-03-16 00:00:00
abstract：:A recent report in Science from the Varmus laboratory (Podsypanina et al., 2008) puts an interesting twist on the origins of metastatic cells, suggesting that metastases can arise in ways that are very different from those widely believed. ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2008.09.009
更新日期：2008-10-07 00:00:00
abstract：:Obesity increases hepatocellular carcinoma (HCC) risks via unknown mediators. We report that hepatic unconventional prefoldin RPB5 interactor (URI) couples nutrient surpluses to inflammation and non-alcoholic steatohepatitis (NASH), a common cause of HCC. URI-induced DNA damage in hepatocytes triggers inflammation via...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.05.020
更新日期：2016-07-11 00:00:00
abstract：:8p11 myeloproliferative syndrome (EMS) is a hematopoietic stem cell disorder characterized by myeloid hyperplasia and non-Hodgkin's lymphoma with chromosomal translocations fusing several genes, most commonly ZNF198, to fibroblast growth factor receptor-1 (FGFR1). However, patients with BCR-FGFR1 fusion present with t...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(04)00053-4
更新日期：2004-03-01 00:00:00
abstract：:Hepatocyte I kappaB kinase beta (IKK beta) inhibits hepatocarcinogenesis by suppressing accumulation of reactive oxygen species (ROS) and liver damage, whereas JNK1 activation promotes ROS accumulation, liver damage, and carcinogenesis. We examined whether hepatocyte p38 alpha, found to inhibit liver carcinogenesis, a...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2008.06.016
更新日期：2008-08-12 00:00:00
abstract：:Identifying contexts in which cancer cells become addicted to specific nutrients is critical for developing targeted metabolic therapies. In this issue of Cancer Cell, Momcilovic et al. report that suppressed glycolysis following mTOR inhibition is countered by adaptive glutamine catabolism in lung squamous cell carci...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2018.04.009
更新日期：2018-05-14 00:00:00
abstract：:Recent structural studies of epidermal growth factor receptor (EGFR) family extracellular regions have identified an unexpected mechanism for ligand-induced receptor dimerization that has important implications for activation and inhibition of these receptors. Here we describe the 2.8 angstroms resolution X-ray crysta...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.03.003
更新日期：2005-04-01 00:00:00
abstract：:Atypical protein kinase C (aPKC) isozymes, PKCλ/ι and PKCζ, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2019.07.010
更新日期：2019-09-16 00:00:00
abstract：:Adaptive resistance to PI3K-mTOR inhibitors potentially limits the clinical antitumor activities of these agents. In this issue of Cancer Cell, Britschgi and coworkers show that certain tumors acquire resistance to PI3K-mTOR inhibitors through activation of a JAK2-dependent pathway, leading to interleukin-8 secretion....
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2012.11.012
更新日期：2012-12-11 00:00:00
abstract：:Human T cell leukemias can arise from oncogenes activated by specific chromosomal translocations involving the T cell receptor genes. Here we show that five different T cell oncogenes (HOX11, TAL1, LYL1, LMO1, and LMO2) are often aberrantly expressed in the absence of chromosomal abnormalities. Using oligonucleotide m...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(02)00018-1
更新日期：2002-02-01 00:00:00
abstract：:Drug delivery systems for cancer therapeutics have now been used by millions of patients and have resulted in the creation of new therapies as well as significantly improving existing ones. Here we discuss a number of the drug delivery systems that have been approved by regulatory authorities and that are currently in...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(03)00276-9
更新日期：2003-11-01 00:00:00
abstract：:Glioma-initiating cells (GICs) are responsible for the initiation and recurrence of gliomas. Here, we identify a molecular mechanism that regulates the self-renewal capacity of patient-derived GICs. We show that TGF-beta and LIF induce the self-renewal capacity and prevent the differentiation of GICs. TGF-beta induces...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2009.02.011
更新日期：2009-04-07 00:00:00
abstract：:Oncoproteins and tumor suppressors antagonistically converge on critical nodes governing neoplastic growth, invasion, and metastasis. We discovered that phosphorylation of the ETS1 and ETS2 transcriptional oncoproteins at specific serine or threonine residues creates binding sites for the COP1 tumor suppressor protein...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2014.06.026
更新日期：2014-08-11 00:00:00
abstract：:Mutations in the EGFR kinase are a cause of non-small-cell lung cancer. To understand their mechanism of activation and effects on drug binding, we studied the kinetics of the L858R and G719S mutants and determined their crystal structures with inhibitors including gefitinib, AEE788, and a staurosporine. We find that ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2006.12.017
更新日期：2007-03-01 00:00:00
abstract：:In the July issue of Nature Medicine, Massagué and colleagues define a biphasic role for the extracellular matrix protein tenascin C as a metastatic niche component in lung colonization by breast cancer cells. These results provide a rationale for designing therapies targeting metastatic progression by disrupting its ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.08.004
更新日期：2011-08-16 00:00:00
abstract：:Agonistic antibodies specific for members of the tumor necrosis factor receptor protein family hold great promise for immunotherapy of cancer. In this issue of Cancer Cell, White and colleagues provide evidence that the human IgG2 subclass may represent a superior backbone for the use of these antibodies in human ther...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2014.12.010
更新日期：2015-01-12 00:00:00
abstract：:Medulloblastoma (MB) is the most common malignant brain tumor in children. Patients whose tumors exhibit overexpression or amplification of the MYC oncogene (c-MYC) usually have an extremely poor prognosis, but there are no animal models of this subtype of the disease. Here, we show that cerebellar stem cells expressi...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.12.021
更新日期：2012-02-14 00:00:00
abstract：:The nervous system is emerging as a regulator of malignancy. In this issue of Cancer Cell, Hayakawa et al. demonstrate a feedforward signaling loop in which tumor-derived nerve growth factor promotes enteric tumor innervation, and recruited nerves drive cancer growth through acetylcholine-regulated Wnt signaling and s...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2016.12.008
更新日期：2017-01-09 00:00:00
abstract：:We used an experimental murine cancer metastasis model in which a colon adenocarcinoma cell line generates lung metastases, whose growth is stimulated in response to injection of bacterial lipopolysaccharide (LPS), to investigate the role of NF-kappaB in inflammation-induced tumor growth. We found that LPS-induced met...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2004.08.012
更新日期：2004-09-01 00:00:00
abstract：:In a recent study, Leucci et al. report a role for the long non-coding RNA SAMMSON in driving mitochondrial function in melanoma. Targeting SAMMSON, the gene of which is frequently co-amplified with MITF, highlights a new cell-type-specific therapeutic vulnerability in melanoma irrespective of BRAF, NRAS, or p53 statu...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2016.04.010
更新日期：2016-05-09 00:00:00
abstract：:In this issue of Cancer Cell, Wieland et al. uncover a feedback loop in which tumor cells, by augmenting Notch signaling, provoke a senescent and pro-inflammatory state in endothelial cells, promoting neutrophil infiltration, tumor cell adhesion, and metastasis. Interfering with this Notch-dependent crosstalk may be a...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2017.02.016
更新日期：2017-03-13 00:00:00
abstract：:Beta-catenin and Tcf4 are the downstream effectors of the Wnt signaling cascade. In colorectal cancer, mutations in Wnt cascade genes such as APC lead to the inappropriate formation of beta-catenin/Tcf4 complexes. Earlier work has predicted that disruption of the beta-catenin/Tcf4 protein-protein interaction could rev...
journal_title：Cancer cell
pub_type： 评论,杂志文章,评审
doi：10.1016/s1535-6108(03)00339-8
更新日期：2004-01-01 00:00:00
abstract：:Activating mutations in GNAQ/GNA11, encoding Gαq G proteins, are initiating oncogenic events in uveal melanoma (UM). However, there are no effective therapies for UM. Using an integrated bioinformatics pipeline, we found that PTK2, encoding focal adhesion kinase (FAK), represents a candidate synthetic lethal gene with...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2019.01.009
更新日期：2019-03-18 00:00:00
abstract：:PPARgamma is a member of the nuclear receptor family for which agonist ligands have antigrowth effects. However, clinical studies using PPARgamma ligands as a monotherapy failed to show a beneficial effect. Here we have studied the effects of PPARgamma activation with chemotherapeutic agents in current use for specifi...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2007.02.025
更新日期：2007-05-01 00:00:00
abstract：:The telomere-stabilizing enzyme telomerase is induced in tumors and functionally associated with unlimited replicative potential. To further explore its necessity, transgenic mice expressing SV40 or HPV16 oncogenes, which elicit carcinomas in pancreas and skin, respectively, were rendered telomerase-deficient. Absence...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2004.08.032
更新日期：2004-10-01 00:00:00
